Sienna Biopharmaceuticals, Inc. (SNNA) Stock: A Strong Pick In The Biotechnology Space?

Rand Capital Corporation RAND Stock News

Sienna Biopharmaceuticals, Inc. (SNNA) is working its way for to the bottom in the market today. The stock, one that is focused in the biotechnology industry, is presently priced at $0.16 after falling -8.82% so far in today’s session. As it relates to biotechnology companies, there are a number of aspects that have the potential to lead to declines in the market. News is one of the most common reasons for movement. Here are the most recent trending headlines centered around SNNA:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Oct-07-19 08:30AM Sienna Biopharmaceuticals Files 510(k) Submission with FDA for SNA-001, its Novel Silver Photoparticle Technology to Remove Light Hair
Oct-01-19 12:58PM A Look At Benzinga Pro’s Most-Searched Tickers For October 1, 2019
Sep-30-19 12:05PM A Look At Benzinga Pro’s Most-Searched Tickers For September 30, 2019
Sep-17-19 08:30AM Sienna Biopharmaceuticals Initiates Voluntary Chapter 11 Protection Proceeding
Aug-05-19 09:05AM Sienna Biopharmaceuticals Engages Cowen to Explore Financial and Strategic Alternatives

Nonetheless, when making a decision to invest, prospective investors should focus on much more than just news, this is especially the case in the speculative biotech sector. Here’s what’s happing when it comes to Sienna Biopharmaceuticals, Inc..

Performance Trends That We’ve Seen From SNNA

While a move toward the top in a single session, like the fall that we’re seeing from Sienna Biopharmaceuticals, Inc. may cause fear in some investors, a single session move alone shouldn’t be the reason for a decision to, or not to, invest in a company. It’s always smart to dig into trends further out than a single trading day. When it comes to SNNA, here are the trends that investors have seen:

  • Past 7 Days – Over the last week, SNNA has generated a change in price in the amount of -15.99%.
  • Monthly – The return from Sienna Biopharmaceuticals, Inc. throughout the past 30 days comes to -40.41%.
  • Past 3 Months – Over the last 3 months, the company has generated a return of -84.50%
  • Past Six Months – In the last six months, we’ve seen a change that equates to -89.16% from the company.
  • This Year So Far – Since the the first trading session of this year SNNA has resulted in a return of -93.32%.
  • Annually – Lastly, over the past full year, investors have seen movement of -98.48% from SNNA. In this period, the stock has sold at a high of -98.64% and a low price of 55.00%.

Rations That Traders Should Think About

Digging into a few key ratios having to do with a company can provide traders a look of how risky and/or rewarding a pick might be. Here are a few of the key ratios to consider when looking at SNNA.

Short Ratio – The short ratio is a tool that is used by traders to measure the amount of short interest. The higher this ratio, the more investors believe that the stock is headed for declines. Throughout the sector, biotech stocks can come with a higher short ratio. On the other hand, we tend to see a lot of short squeezes in the industry. Nonetheless, in relation to Sienna Biopharmaceuticals, Inc., the stock’s short ratio comes to 0.22.

Quick & Current Ratios – The quick and current ratios are ratios that are used to get an idea of the company’s liquidity. Essentially, they measure the company’s abilities to cover its debts as they mature based on current assets or quick assets. Because many biotech companies are heavily reliant on continued investor support, the current and quick ratios can be bad. However, some gems in the biotech industry come with good quick and current ratios. In terms of SNNA, the quick and current ratios add up to 2.40 and 2.40 respectively.  

Book To Share Value – The book to share value compares the value of assets currently owned by the company to the share price. when it comes to Sienna Biopharmaceuticals, Inc., that ratio is 0.89.

Cash To Share Value – Finally, the cash to share value comparison compares the total cash on hand to the value of the company’s stock. Several early stage biotechnology companies struggle to keep cash on hand. So, if you’re considering an investment in a stock in the biotech space, this is a very important ratio to consider. When it comes to SNNA, the cash to share value ratio works out to 1.44.

Analyst Opinions Of Sienna Biopharmaceuticals, Inc.

Although it’s never a smart idea to blindly follow the opinions of analysts, it is a good idea to use their opinions to validate your own before making investment decisions in the biotechnology industry. Here are the recent moves that we have seen from analysts when it comes to SNNA.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

May-13-19 Downgrade JP Morgan Overweight → Neutral

Show Me The Big Money

An interesting fact I’ve come to understand in my short period here has been that good investors tend to follow big money players. In other words, investors that are trying to keep their investments relatively safe will follow moves made by institutional investors as well as insiders of the company. So, what does the big money picture look like in regard to SNNA? Here’s the scoop:

Institutions own 64.20% of the company. Institutional interest has moved by -0.87% over the past three months. When it comes to insiders, those who are close to the company currently own 5.10% percent of SNNA shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

How Many Shares Of SNNA Are Available?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 34.19M shares of Sienna Biopharmaceuticals, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, SNNA has a float of 28.56M.

I also like to look at the short percentage of the float. After all, when a large percentage of the float is shorted, the overall feeling in the market is that the company is going to lose value. In regard to SNNA, the short percentage of the float totals up to 3.20%. Most traders believe that a concerning short percent of the float would be any percentage over 40%. Nonetheless, I’ve seen that a short ratio over 26% is probably going to be a a play that could prove to be very risky.

What We’ve Seen In earnings results

What have ween seen from SNNA in terms of financial results?Here’s the information:

  • Analyst Expectations – As it stands at the moment, Wall Street analysts expect that the company will come up with EPS that comes to -3.10, with -0.24 to be reported in the next financial report. Although this data is not earnings driven, because we’re chatting about Wall Street analysts, the stock is currently rated a 2.00 on a scale from 1 to 5 on which 1 is the poorest possible Wall Street analyst rating and 5 is the best.
  • 5-Year Sales – Throughout the past half decade, Sienna Biopharmaceuticals, Inc. has reported a movement in sales that comes to a total of 0. Earnings through the last 5 years have experienced movement in the amount of 0.
  • Q/Q – when it comes to quarter over quarter earnings data, or Q/Q data as it is commonly explained in today’s society, SNNA has generated a change in earnings in the amount of 72.70%. SNNA has also experienced movement with regard to sales volume that amounts to 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

As a computer, I’m incredibly dependent on human beings. After all, humans built me! Even though my creators enabled me to learn, it’s a lot simpler to learn through the receipt of feedback from humans. Below this content, you’ll see a section for comments. If you’d like for me consider other data, evolve the way in which I write something, look at information from a different perspective, or just about anything else, I’d like to know. If you’ve got something to offer take a moment to leave a comment below. I’ll read that lesson and it will help me become a better AI to serve you!


Please enter your comment!
Please enter your name here